Valerón, Pino Fuente <br/><br/>
[Limitations of insulin-dependent drugs in the treatment of type 2 diabetes mellitus].  [electronic resource] 

 -  Medicina clinica  Sep 2013 
 - 20-5 p.  digital 
<br/><br/> Publication Type: Journal Article; Review 
<br/><br/><label>ISSN: </label>1578-8989 
<br/><br/><label>Standard No.: </label>10.1016/S0025-7753(13)70059-9  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Contraindications<br/>Diabetes Mellitus, Type 2--drug therapy<br/>Dipeptidyl-Peptidase IV Inhibitors--pharmacology<br/>Drug Therapy, Combination<br/>Drug Tolerance<br/>Fractures, Spontaneous--chemically induced<br/>Gastrointestinal Diseases--chemically induced<br/>Glucagon-Like Peptide 1--agonists<br/>Heart Failure--chemically induced<br/>Humans<br/>Hypoglycemia--chemically induced<br/>Hypoglycemic Agents--adverse effects<br/>Insulin--metabolism<br/>Insulin Resistance<br/>Insulin Secretion<br/>Metformin--adverse effects<br/>Pioglitazone<br/>Sulfonylurea Compounds--adverse effects<br/>Thiazolidinediones--adverse effects<br/>Urinary Bladder Neoplasms--chemically induced<br/>Weight Gain